Chew bet you

Medical chewing gum specialist Fertin Pharma A/S
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
COPENHAGEN—Medical chewing gum specialist Fertin Pharma A/S announced it would collaborate with the U.S. Army Dental Research and Trauma Detachment (USADRTD) for the development of antimicrobial chewing gum for the treatment and prevention of plaque, cavities, and gum disease. Dental emergencies represent an ongoing and significant challenge to the U.S. military as it tries to deploy troops overseas.
 
"Together, we will continue the USADTRD mission of developing a product that can improve dental health among first of all US deployed military forces, but secondly is a promising and highly interesting candidate for wide distribution to the public," says Lars Christian Nielsen, Fertin Pharma CEO.
 
The deal will see Fertin scientists formulate the USADRTD's antimicrobial decapeptide for controlled release in the oral cavity. The success of nicotine gums—Nicorette alone had 2005 sales of $171 million—has led to widespread acceptance of this form of drug delivery.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Tackling mycoplasma contamination in biotherapeutic production
DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.
Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.
Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue